STAT

Opinion: Facing deaths of despair from the depths of despair in West Virginia

I'm helping turn West Virginia into a laboratory to test new solutions for fighting the opioid crisis. Other states can do the same.
Charles Nelson and Janette Bolen wait in line for free groceries outside of Welch, West Virginia. Addressing issues of food scarcity is one method of tackling the opioid epidemic.

I left my home state of West Virginia 30 years ago to embark on a career in internal medicine. What drew me back in 2015 was the opioid crisis — and the even bigger health crisis it is part of.

Opioid addiction takes a greater toll in West Virginia than in any other state. In 2016, the last year with complete statistics, a West Virginian was dying of a drug overdose every 10 hours. As a physician who helps manage the largest medical system in West Virginia, I’ve learned that as big as the opioid addiction crisis is in our state, it is not the root problem. Instead, it is a symptom of a much larger problem, one of hopelessness, isolation, and despair.

It’s this problem

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks